封面
市场调查报告书
商品编码
1768087

医疗保健合约研究外包市场按服务类型、最终用户和地区划分

Healthcare Contract Research Outsourcing Market, By Services Type, By End User (CROs, Clinical Trial Laboratories, and AMCs), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3个工作天内

价格
简介目录

医疗保健合约研究外包市场规模预计在 2025 年达到 1,726.3 亿美元,预计到 2032 年将达到 4,620 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 15.1%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 1726.3亿美元
效能数据 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 15.10% 2032年价值预测 4620亿美元

医疗保健合约研究外包由製药和医疗设备产业承担,用于开发新药和医疗设备。临床试验是药物和医疗设备开发的重要组成部分,目前,临床试验在不同地区的多个地点进行。药物开发成本和时间的不断增长预计将在预测期内推动全球医疗保健委託市场的成长。此外,关键药物专利到期数量的增加也有望推动市场成长。

市场动态

日益增多的合作与伙伴关係正在促进全球医疗研究外包市场的成长。例如,2022年9月,提供全球端到端开发服务的医疗设备合约研发组织 (CRO) 北美科学协会 (NAMSA) 与 CGuard 栓塞预防系统 (EPS) 的开发商 InspireMD, Inc. 达成外包伙伴关係伙伴关係,以加速医疗设备的开发和商业化。 CGuard 栓塞预防系统用于治疗颈动脉疾病和预防中风。

本研究的主要特点

  • 本报告对全球医疗保健合约研究外包市场进行了详细分析,并以 2024 年为基准年,展示了预测期 2025 年至 2032 年的市场规模(十亿美元)和復合年增长率。
  • 它还强调了各个领域的潜在商机,并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球医疗保健合约研究外包市场的主要企业已根据公司概况、业务绩效、产品系列、市场影响、分销策略、关键发展、策略和未来计划等参数进行了分析。
  • 研究中涉及的关键公司包括 IQVIA Inc.、Covance Inc.(Labcorp 的子公司)、Pharmaceutical Product Development Inc.(Thermo Fisher Scientific 的子公司)、Parexel International (MA) Corporation、Charles River Laboratories、ICON plc、Medidata、Inventiv Health, Inc.(Syneos Ltd. 的子公司)。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、技术改进、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该产业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 可以透过用于分析全球医疗合约研究外包市场的各种策略矩阵来促进相关人员的决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 市场机会
  • 影响分析
  • 最新产品发布
  • 流行病学
  • 合併、收购和合作
  • 监管情景
  • 主要进展
  • PEST分析

4. 全球医疗保健合约研究外包市场(依服务类型),2020 年至 2032 年

  • 临床试验
  • 监管服务
  • 医学写作
  • 临床数据管理
  • 其他的

5. 全球医疗保健合约研究外包市场(按最终用户划分),2020 年至 2032 年

  • CRO
  • 临床试验实验室
  • AMC

6. 全球医疗保健合约研究外包市场(按地区划分),2020 年至 2032 年

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韩国
      • 其他亚太地区
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第七章 竞争态势

  • IQVIA Inc.
  • Covance Inc(A subsidiary of Labcorp)
  • Pharmaceutical Product Development Inc(A subsidiary of Thermo Fisher Scientific Inc.)
  • Parexel International(MA)Corporation
  • Charles River Laboratories
  • ICON plc
  • Medidata
  • Inventiv Health, Inc.(A subsidiary of Syneos Health)
  • Medpace
  • Piramal Enterprises Ltd.

第 8 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI3788

Healthcare Contract Research Outsourcing Market is estimated to be valued at USD 172.63 Bn in 2025 and is expected to reach USD 462.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 172.63 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 15.10% 2032 Value Projection: USD 462.00 Bn

Healthcare contract research outsourcing is conducted by the pharmaceutical and medical device sectors for the development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development, and in the current scenario, clinical trials are conducted across multiple locations in various geographies. Increasing cost and time required for drug development are expected to propel the global healthcare contract research outsourcing market growth over the forecast period. Furthermore, the increasing number of patent expirations of leading drugs is also expected to aid in the growth of the market.

Market Dynamics

Increasing incidences of collaborations and partnerships are attributed to the growth of the global healthcare contract research outsourcing market. For instance, in September 2022, North American Science Associates, LLC (NAMSA), a Medical Devices Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc., a developer of the CGuard Embolic Prevention System (EPS) for the treatment of carotid artery disease and prevention of strokes, entered an outsourcing partnership to accelerate medical device development and commercialization.

Key features of the study

  • This report provides an in-depth analysis of the global healthcare contract research outsourcing market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global healthcare contract research outsourcing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
  • The key companies covered as a part of this study include, IQVIA Inc., Covance Inc (a subsidiary of Labcorp), Pharmaceutical Product Development Inc (a subsidiary of Thermo Fisher Scientific Inc), Parexel International (MA) Corporation, Charles River Laboratories, ICON plc, Medidata, Inventiv Health, Inc. (A subsidiary of Syneos Health), Medpace, and Piramal Enterprises Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global healthcare contract research outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare contract research outsourcing market.

Market Segmentation

  • Global Healthcare Contract Research Outsourcing Market, By Services Type
    • Clinical Trials
    • Regulatory Services
    • Medical Writing
    • Clinical Data Management
    • Others
  • Global Healthcare Contract Research Outsourcing Market, By End User
    • CROs
    • Clinical Trial Laboratories
    • AMCs
  • Global Healthcare Contract Research Outsourcing Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • IQVIA Inc.
    • Covance Inc (A subsidiary of Labcorp)
    • Pharmaceutical Product Development Inc (A subsidiary of Thermo Fisher Scientific Inc.)
    • Parexel International (MA) Corporation
    • Charles River Laboratories
    • ICON plc
    • Medidata
    • Inventiv Health, Inc. (A subsidiary of Syneos Health)
    • Medpace
    • Piramal Enterprises Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Services Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Healthcare Contract Research Outsourcing Market, By Service Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Clinical Trials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
      • Drug Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
  • Regulatory Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Medical Writing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Clinical Data Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

5. Global Healthcare Contract Research Outsourcing Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • CROs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • Clinical Trial Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
  • AMCs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

6. Global Healthcare Contract Research Outsourcing Market, By Region, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • IQVIA Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covance Inc (A subsidiary of Labcorp)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pharmaceutical Product Development Inc (A subsidiary of Thermo Fisher Scientific Inc.)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Parexel International (MA) Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ICON plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medidata
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Inventiv Health, Inc. (A subsidiary of Syneos Health)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medpace
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Piramal Enterprises Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

8. Section

  • Research Methodology
  • About Us